Background
==========

Nearly 25% of seniors over the age of 85 years reside in long-term care facilities in the United States \[[@B1]\]. These individuals are prescribed a greater number of medications than those residing in the community \[[@B2],[@B3]\]. Inappropriate prescribing has been reported to be higher among elderly in long-term care, compared to community dwelling elderly, with estimates as high as 33% to 40% \[[@B4]-[@B6]\]. Multiple medical illnesses, functional impairment and cognitive deficits contribute to a higher risk of adverse drug reactions in the elderly residing in long-term care \[[@B7]\]. Adverse outcomes, including hospital admissions, increased cost and delirium have been associated with inappropriate prescribing \[[@B6],[@B8]-[@B10]\].

Guidelines in both Canada \[[@B11]\] and the United States \[[@B12],[@B13]\] have been developed to guide prescribing for the elderly. Through a Delphi consensus process, McLeod and colleagues \[[@B11]\] proposed prescribing guidelines (with 38 recommendations) that incorporated Canadian practices and updated the Beers guidelines \[[@B12]\]. A shorter version of the McLeod guidelines was pilot tested in both acute and long-term care \[[@B14],[@B15]\]. The studies required manual abstraction from patient charts.

Translation of evidence-based guidelines into practice may be facilitated by computerized instruments, which detect and flag potentially inappropriate prescriptions. Computerized tools in acute care have been shown to be effective in identifying adverse drug events and inappropriate drug dosing, and improving prescribing practices \[[@B16]-[@B18]\].

The goal of this study was to develop and test the reliability of a computer program, which would identify potentially inappropriate drug prescriptions, based on a modified version of the McLeod guidelines.

Methods
=======

Study design
------------

The administrative database from one pharmacy providing service to a long-term care facility was used in this cross-sectional study. The pharmacy provides service to approximately 200 facilities in Ontario. Complete prescription information was voluntarily provided for the month of November 2000 for 356 long-term care residents. The university ethics review board granted approval for the study. All patient, physician and facility identifying numbers were scrambled to preserve confidentiality.

The pharmacy database included the following information: the age and sex of the residents, their Ontario Health Insurance Plan number, and the prescriptions dispensed to each of the residents in the long term care facility. Drug prescription information included the date the prescription was filled, the dose and quantity of drug prescribed and the eight-digit drug identification number. Patient diagnoses were not available from the database. Linkage between the pharmacy database and the computer-based program developed to identify inappropriate prescriptions involved two steps. First, an anonymized version of the pharmacy database was exported into a Microsoft Excel format. Second, the Excel file was imported into a Microsoft Visual FoxPro table structure.

Classification of inappropriate prescriptions
---------------------------------------------

There were 38 potentially inappropriate prescriptions defined using the McLeod guidelines \[[@B11]\]. Since disease information was not available from the pharmacy database, the inappropriate practices, which fell within the category \"drug disease interactions\", were modified, using drug prescriptions as surrogates for the disease state. For example, the McLeod guidelines described the prescription of a beta-blocker to an elderly individual with chronic obstructive pulmonary disease as potentially inappropriate. For the purpose of our study, we defined chronic obstructive pulmonary disease as any person who was prescribed a beta-adrenergic agonist or a bronchial anti-inflammatory agent. Thus, any resident who was prescribed one of these drugs and a beta-adrenergic blocking agent would have been flagged as having received a potentially inappropriate prescription. Long-term prescription was defined as prescription of a medication for 2 weeks or greater. Drug prescriptions were used as surrogates for the following disease conditions: chronic obstructive pulmonary disease, gout, glaucoma, benign prostate hyperplasia, heart failure, hypertension, peptic ulcer disease, and osteoarthritis.

Further, several assumptions were made that drugs were only used for the treatment of a specified disease. For example, for the practice: \"Prescription of a thiazide diuretic to treat hypertension for patients with a history of gout\", we assumed that a thiazide diuretic was always prescribed for hypertension. Similarly, for the practice: \"Prescription of NSAIDS to treat osteoarthritis for patients with history of peptic ulcer\", we assumed that NSAIDS were always prescribed for osteoarthritis.

Recommendations related to diseases that lacked a prescription drug marker and drugs that were no longer routinely prescribed were not applied to the study (Table [1](#T1){ref-type="table"}). In total we used 27 of the original 38 recommendations that were modified to accommodate the pharmacy database.

###### 

Inappropriate prescribing practices outlined in McLeod guidelines that were excluded in the current study

  ------------------------------------------------------------------------------------------------------------------------------------
  Prescription of B-adrenergic blocking agent to treat angina for patients with history of asthma, COPD or heart failure
  Prescription of calcium-channel blocker to treat hypertension for patients with history of heart failure
  Prescription of B-adrenergic blocking agent to treat hypertension for patients with history of heart failure
  Long-term prescription of B-adrenergic blocking agent to treat angina or hypertension for patients with history of Raynaud disease
  Prescription of tricyclic antidepressant to treat depression for patients with a history of postural hypotension
  Prescription of ASA to treat pain for patients already receiving warfarin
  Long-term prescription of NSAIDs to treat osteoarthritis for patients with chronic renal failure
  Prescription of phenylbutazone to treat chronic osteoarthritis
  Prescription of anticholinergic or antispasmodic drugs to treat irritable bowel syndrome or patients with dementia
  Prescription of dipyridamole to prevent stroke
  Long-term prescription of orally administered steroids to treat COPD for patients with history of NIDDM
  ------------------------------------------------------------------------------------------------------------------------------------

Descriptive statistics were used to characterize the patient sample and the proportion of inappropriate prescriptions according to the McLeod guidelines.

Computer program
----------------

Microsoft\'s Visual Fox Pro Version 6.0, a database development system was used to construct two algorithms: 1) a data set generator algorithm and 2) an inappropriate prescription detection algorithm. Both algorithms were developed using FoxPro\'s Visual basic and Structured Query Language components. The data set generator algorithm randomly generated two mock patient data sets containing both appropriate and inappropriate prescriptions. These data sets provided error free data where both manual abstractors and the computer programmer could refine the inappropriate prescription detection algorithm while remaining blind to the contents of the data set until after the inappropriate prescription detection was conducted. The data set generator algorithm contained four parameters: 1) the number of patients to be contained in the data set, 2) a minimum number of inappropriate prescriptions per patient, 3) the total number of prescriptions per patient, and 4) the class of inappropriate prescriptions to include.

The second algorithm, based on the relevant McLeod \[[@B11]\] recommendations, was used to detect inappropriate prescriptions. Drugs were identified using their drug identification numbers, as listed in the Ontario Drug Benefit Formulary for 2000. The inappropriate prescription detection algorithm was designed to flag both kinds of inappropriate prescriptions: those where a single drug indicated an inappropriate prescription and those where the combination of two drugs indicated an inappropriate prescription. Using this data set, the algorithm ran three scans of the patient\'s prescriptions. The first scan detected and flagged single inappropriate prescriptions while the second and third scan were used to detect combination inappropriate prescriptions. The second scan pulled out all possible prescription combinations per patient. Finally, the third scan extracted combination inappropriate prescriptions from the second scan\'s results.

The reliability of the computer program was assessed by comparing the results obtained with the program to a manual search conducted by two independent research assistants blinded to the results of the computer program. Each assistant reviewed each patient chart, provided from the pharmacy, independently with an abstraction form. They were provided with a brief training session on abstraction of variables by a pharmacist. A case-by-case comparison of the results was made from the computer and manual reviews. The following information was gathered by computer and manual abstraction: the number of potential inappropriate prescriptions per person, total potential inappropriate prescriptions, the type of potential inappropriate prescription and the combination of drugs prescribed inappropriately.

Results
=======

Data was abstracted for 356 elderly residents, the majority of whom were Caucasian. There were 276 females and 80 males with an age range of 44 to 102 years and mean age (+standard deviation) of 84.2 ± 8.1 years. There was complete agreement between the computer and manual abstraction for the following: total number of potential inappropriate prescriptions detected, the number of potential inappropriate prescriptions per person, type of potential inappropriate prescription and the combination of drugs prescribed inappropriately.

In total, 83 potential inappropriate prescriptions were identified. Of all residents, fifty-three (14.9%) received at least one potential inappropriate prescription. Of those, twenty (37.7%) were identified as having at least two potential inappropriate prescriptions and eight (15.1%) were identified as having 3 or more potential inappropriate prescriptions.

Table [2](#T2){ref-type="table"} describes the proportion of patients given inappropriate prescription according to classification by the McLeod guidelines. Non-steroidal anti-inflammatory agents and other analgesics comprised the majority of the total number of potential inappropriate prescriptions (n = 39; 47%). Non-steroidal anti-inflammatory agents were commonly prescribed in combination with diuretics indicating a history of heart failure or hypertension (n = 13; 15.7%) and in combination with histamine-2 antagonists or proton pump inhibitors for patients indicating a history of peptic ulcer disease (n = 5; 6.0%). The second most common class of inappropriate medications involved prescription of psychotropic drugs (n = 30; 36.1%). For psychotropic drugs, prescription of a tricyclic antidepressant with active metabolite (n = 17; 20.5%) or a tricyclic antidepressant in combination with glaucoma or prostate medication (n = 8; 13.6%), were the most common potential inappropriate prescriptions in this category. Long-term prescription of long-acting benzodiazepines and barbituates were uncommon in this population. Of the total potential inappropriate prescriptions, 6 (7.2%) were inappropriately prescriptions of anticholinergic drugs with antipsychotic medication.

###### 

Number of Inappropriate Prescriptions (%) according to classification by McLeod et al. (of original 38 recommendations).

  **Practice -- McLeod Guideline**                                                                                                                         **Our Definition using drug prescription surrogates**                                                                 **Inappropriate Prescriptions n (%)**
  -------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------- ---------------------------------------
  Total inappropriate practices -- Cardiovascular diseases                                                                                                                                                                                                                       **6 (7.2)**
  γ^\#^Prescription of B-adrenergic blocking agent to treat hypertension for patients with history of asthma or COPD                                       Prescription of B-adrenergic blocking agent with B-agonist or bronchial anti-inflammatory agent                       5 (6.0)
  ^\#^Prescription of disopyramide to treat atrial fibrillation                                                                                            Prescription of disopyramide                                                                                          0 (0.0)
  γ^\#^Prescription of thiazide diuretic to treat hypertension for patients with history of gout                                                           Prescription of thiazide diuretics with gout medication (e.g. allopurinol)                                            1 (1.2)
  Total inappropriate practices -- Psychotropic Drugs                                                                                                                                                                                                                            **30 (36.1)**
  \*^\#^Long-term prescription of long half-life benzodiazepine to treat insomnia                                                                          Long-term prescription of any long half-life benzodiazepine (e.g. valium)                                             4 (4.8)
  ^\#^γPrescription of tricyclic antidepressants to treat depression for patients with history of glaucoma, benign prostatic hyperplasia, or heart block   Prescription of tricyclic antidepressant with glaucoma or prostate medication                                         8 (13.6)
  \*^\#^Long-term prescription of barbituate to treat insomnia                                                                                             Long-term prescription of any barbituate                                                                              1 (1.2)
  ^\#^Prescription of selective serotonin reuptake inhibitor for patients already receiving a monoamine oxidase inhibitor to treat depression              Prescription of selective serotonin reuptake inhibitor for patients already receiving a monoamine oxidase inhibitor   0 (0.0)
  \*^\#^Long term prescription of triazolam to treat insomnia                                                                                              Long-term prescription of triazolam                                                                                   0 (0.0)
  ^\#^Prescription of chlorpromazine to treat psychosis for patients with history of postural hypotension                                                  Prescription of chlorpromazine                                                                                        0 (0.0)
  ^\#^Prescription of nylidrin, niacin, pentoxifylline to treat dementia                                                                                   Prescription of nylidrin, niacin or pentoxifylline                                                                    0 (0.0)
  ^\#^Prescription of tricyclic antidepressants with active metabolites to treat depression                                                                Prescription of tricyclic antidepressants                                                                             17 (20.5)
  ^\#^Prescription of methylphenidate to treat depression                                                                                                  Prescription of methylphenidate                                                                                       0 (0.0)
  **Total inappropriate practices -- NSAIDS and other analgesics**                                                                                                                                                                                                               **39 (47.0)**
  ⊥^\#^γPrescription of NSAIDS to treat osteoarthritis for patients with a history of peptic ulcer                                                         Prescription of NSAIDS with histamine 2 antagonists or proton pump inhibitors                                         5 (6.0)
  \*Long term prescription of meperidine or pentazocine for pain                                                                                           Long term prescription of meperidine or pentazocine                                                                   0 (0.0)
  ⊥^\#^Prescription of NSAIDS to treat osteoarthritis for patients taking warfarin                                                                         Prescription of NSAIDS with warfarin                                                                                  3 (3.6)
  ⊥^\#^\*γ^+^Long-term prescription of NSAIDS to treat osteoarthritis for patients with history of heart failure or hypertension                           Prescription of NSAIDS with diuretics                                                                                 13 (15.7)
  \*^\#^Long term prescription of piroxicam, ketorolac, or mefenamic acid to treat pain                                                                    Long term prescription of piroxicam, ketorolac or mefenamic acid                                                      0 (0.0)
  \*^\#^γLong term prescription of indomethacin to treat gout                                                                                              Long term prescription of indomethacin with gout medication (e.g. allopurinol)                                        
  ⊥^\#^\*Long term prescription of NSAIDS to treat osteoarthritis                                                                                          Long term prescription of NSAIDS                                                                                      18 (21.7)
  **Total inappropriate practices -- miscellaneous drugs**                                                                                                                                                                                                                       **8 (9.6)**
  ^\#^Prescription of cimetidine to treat peptic ulcer for patients already receiving warfarin                                                             Prescription of cimetidine with warfarin                                                                              1 (1.2)
  ^\#^Prescription of anticholinergic drugs to prevent extrapyramidal effects of antipsychotic drugs                                                       Prescription of anticholinergic drugs (e.g. congentin) with antipsychotic drugs (e.g. risperdal)                      6 (7.2)
  ^\#^\*Long term prescription of diphyenoxylate to treat diarrhea                                                                                         Long term prescription of diphenoxylate                                                                               0 (0.0)
  ^\#^Prescription of cyclobenzaprine or methocarbamol to treat muscle spasms                                                                              Prescription of cyclobenzaprin or methocarbamol                                                                       1 (1.2)

\*Prescribed longer than 2 weeks, +Recommendations from McLeod guidelines grouped together, γRecommendations from McLeod guidelines that were modified by using drug prescriptions as surrogates for disease states \#Assumption made that drug only used in treatment of specified disease ⊥Excluding ASA (combination or alone) as an inappropriate prescription, including all other NSAIDS

Discussion
==========

The computer program identified all of the potential inappropriate prescriptions as modified from the McLeod guidelines that were captured in the manual abstraction. Although definitions of inappropriate prescribing may need modification based on new research, the computer program can be easily adapted to incorporate necessary changes. The program can be incorporated into a user-friendly interface for clinicians, nurses, or health care workers to use. The advantage of the computer program currently studied is the increased accuracy and efficiency associated with direct linkage of pharmacy database information to the computer inappropriate prescribing program. This program would allow pharmacists, nurses and physicians to review prescribing practices and make evidence based decisions.

The computer program identified that 14.9% of residents had at least one potential inappropriate prescription according to the modified McLeod guidelines \[[@B11]\]. Many inappropriate prescribing practices, such as use of triazolam, chlorpromazine and methylphenidate, were not found. Some of the inappropriate contraindications are not absolute, such as the use of coumadin and aspirin and were excluded from the abstraction \[[@B19]\]. Our results are similar to a recent Canadian study, which used a chart review applying modified McLeod guidelines, and found the prevalence of inappropriate prescriptions to be 18.3% in long-term care. Gill et al found that the most common inappropriate prescribing practices were the use of anticholinergic drugs to manage antipsychotic side effects, tricyclic antidepressants with active metabolites, long-acting benzodiazepines, and non-steroidal anti-inflammatory drugs in patients with a history of peptic ulcer disease, hypertension or renal insufficiency \[[@B15]\].

The majority of potential inappropriate prescriptions in our study involved prescription of non-steroidal anti-inflammatory drugs and psychotropic drugs. Other studies have identified a higher rate of inappropriate prescribing. For example, a Canadian study using modified Beers criteria and McLeod guidelines found that 29.8% patients were prescribed an inappropriate drug in the community and institutions \[[@B20]\]. American studies identified that 33 to 40% of residents in long-term care received an inappropriate drug prescription as defined by modification of Beers 1997 criteria \[[@B4],[@B6]\]. There may be a number of reasons why inappropriate prescribing was lower in our population. Consultant pharmacists involved with the population may be detecting potential inappropriate prescriptions early on, therefore reducing inappropriate prescribing and possibly adverse drug events. Another reducing factor may be the small number of prescribing primary care physicians who specialize in geriatrics in the long term care facility studied. A Canadian provincial database study concluded that as the number of prescribing physicians increases, the patient\'s risk of receiving an inappropriate prescription also increases \[[@B21]\]. Use of different guidelines for detecting inappropriate prescribing may have resulted in lower rates of inappropriate prescriptions in our population.

Easily identifying inappropriate prescribing practices is only one of the barriers to optimizing prescribing \[[@B22]\]. Studies have shown that interventions targeting inappropriate prescribing are effective in long-term care residents. One randomized controlled study of long-term care residents determined the effects of an educational program on non-steroidal anti-inflammatory drug use and clinical outcomes in long-term care. The intervention included the risks and benefits of non-steroidal anti-inflammatory drugs and an algorithm that substituted other therapies for the treatment of non-inflammatory musculoskeletal pain. The intervention was shown to be effective resulting in markedly decreased long-term prescription of non-steroidal anti-inflammatory drugs and increased acetaminophen use \[[@B23]\].

One important limitation of the study was that we did not abstract information on diagnoses from the charts in the long-term care facility. This information is often unavailable from long-term care charts. Prescription medication was used as a surrogate marker for disease states for several criteria, where some surrogates were better indicators than other surrogates for disease states. As a result, we may have somewhat overestimated the rate of inappropriate prescribing for particular categories, outlined here: 1) long-term prescription of barbituates to treat insomnia: regular use of barbituates may still occur in long term care for seizures, however this could not be distinguished from insomnia. 2) prescription of non-steroidal anti-inflammatory agents in those with peptic ulcer: prescription of this medication may have also been used in those with gastroesophageal reflux disease, but it is only considered inappropriate for peptic ulcer. Also, it could not be distinguished whether non-steroidal anti-inflammatory agents were being prescribed with knowledge of a history of peptic ulcer or if gastroprotective agents (i.e. H2 antagonists, proton pump inhibitors) were being prescribed as a result of non-steroidal anti-inflammatory induced gastric toxicity. 3) prescription of tricyclic antidepressants to treat depression for patients with history of benign prostate hyperplasia: prescription of alpha blockers may have also been used for the treatment of hypertension. This limitation of surrogate markers will be resolved only when technological support will permit the electronic integration and manipulation of diagnostic data on individual patients. Another important limitation of the current computer program is lack of linkage to documentation of adverse events from their potentially inappropriate medication use. Modification of the McLeod guidelines is also another possible limitation of this study. However, a literature review of studies using the Beers criteria of inappropriate prescribing determined that most researchers modified the criteria and that inappropriate prescribing was observed despite methodological differences \[[@B24]\].

Conclusions
===========

We found that a computer program can accurately and automatically detect potentially inappropriate prescriptions in residents of long-term care facilities. Although computerized tools have been used to identify inappropriate prescribing in acute care, this is a new and emerging area in the field of long-term care. As previously discussed, the magnitude of the problem of inappropriate prescribing is greater in long-term care (4-6) and the consequences greater due to the frail elderly population (7, 25-26). An automated, accurate computer program would be an inexpensive, efficient alternative to identifying inappropriate prescribing in long-term care elderly. In addition, it would facilitate knowledge transfer since it could be readily adapted to updated practice guidelines.

Future research will be directed at application of this program to a larger patient population in determining if this program can facilitate change in prescribing practices. Also, research will be aimed at determining if changes in prescribing will have an affect on patient outcomes.
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